Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients. Sun X, Mei J, Lin W, Yang Z, et al. BMC Cancer 2021;21:775.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun X, Mei J, Lin W, Yang Z, et al. Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients. BMC Cancer 2021;21:775.
PMID: 34218801